Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-30 Korenberg Matthew E PRESIDENT & CHIEF OPERATING Other acquisition +376 $56.78 $21K 99,124
2023-06-30 Espinoza Octavio Chief Financial Officer Other acquisition +375 $56.78 $21K 24,517
2023-06-09 Sabba Stephen L Director Grant or award +1,142 26,926
2023-06-09 Sabba Stephen L Director Grant or award · Non-Qualified Stock Option (right to buy) −5,461 5,461
2023-06-09 Gray Nancy Ryan Director Grant or award +1,142 6,567
2023-06-09 Gray Nancy Ryan Director Grant or award · Non-Qualified Stock Option (right to buy) +5,461 5,461
2023-06-09 LAMATTINA JOHN L Director Grant or award +1,142 28,263
2023-06-09 LAMATTINA JOHN L Director Grant or award · Non-Qualified Stock Option (right to buy) +5,461 5,461
2023-06-09 KOZARICH JOHN W Director Grant or award +1,142 39,630
2023-06-09 KOZARICH JOHN W Director Grant or award · Non-Qualified Stock Option (right to buy) +5,461 5,461
2023-06-09 Aryeh Jason Director Grant or award +1,142 71,529
2023-06-09 Aryeh Jason Director Grant or award · Non-Qualified Stock Option (right to buy) +5,461 5,461
2023-06-09 Haas Jason Director Grant or award +1,142 4,145
2023-06-09 Haas Jason Director Grant or award · Non-Qualified Stock Option (right to buy) +5,461 5,461
2023-06-09 Davis Todd C CHIEF EXECUTIVE OFFICER Shares withheld for taxes −420 $73.76 $31K 69,090
2023-05-16 KOZARICH JOHN W Director Sale −4,444 $77.20 $343K 38,488
2023-05-10 Sabba Stephen L Director Option exercise +6,408 32,192
2023-05-10 Sabba Stephen L Director Sale −6,408 $77.13 $494K 25,784
2023-05-10 Sabba Stephen L Director Option exercise · Non-Qualified Stock Option (right to buy) −6,408 927
2023-05-08 KOZARICH JOHN W Director Option exercise +6,408 $18.82 $121K 48,621

Page 25 of 43 · 858 trades